Message from the Honorary Presidents of EUROGIN 2011
Dear Friends of EUROGIN,
Thirty-five years ago Professor Harold zur Hausen first proposed that human papillomavirus (HPV) might cause cervical cancer. By 1995 the weight of epidemiologic and molecular biologic data was overwhelming and led the International Agency for Research on Cancer (IARC) to conclude that HPV was the cause of most cervical cancers. The explosive growth in understanding not only the basic science of HPV-induced carcinogenesis, but also how this new information could change clinical practice, created the need for an international conference that could bring together both clinicians and researchers to share and debate the wealth of information as it evolved. The result was the instigation of the first European Research Organization on Genital Infection and Neoplasia (EUROGIN) conference in Paris in 1994. Over the past 16 years EUROGIN has brought together a worldwide community of researchers, clinicians, public health practitioners, epidemiologists, microbiologists, health economists, and disease advocates focused on prevention and treatment of both benign and neoplastic genital HPV disease. As improved cervical screening and management of abnormal findings developed in conjunction with molecular testing and evidence-based guidelines, and HPV vaccination moved from a promising prospect to reality, EUROGIN has been there, stimulating the vibrant discussion and education so critical in moving ideas, technology and clinical use forward. EUROGIN is the largest forum worldwide for clinicians interested in the prevention of cervical and other HPV-associated disease. Its international role is not only established by the remarkable roster of speakers and attendees that come to share their expertise and to learn together, but also by the establishment of sister organizations in Latin America and Asia that focus on specific problems experienced by clinicians, academics, and policymakers at a regional level.
Once a triennial conference, EUROGIN now occurs nearly annually in order to keep up with the rapid expansion of new developments in the prevention of cervical and other HPV-induced cancers. EUROGIN 2011 promises to cross another milestone in both location (Lisbon) and increased focus on understanding new developments in the role of HPV in a range of cancers, including vaginal, vulvar, penile, anal and those of the head and neck. This exploration will be wide ranging, including epidemiology, natural history, prevention and clinical management. The expanded focus of EUROGIN 2011 on all HPV-induced neoplasia is reflected in the title of the conference “HPV ASSOCIATED DISEASES AND CANCER: FROM REALITY NOW TO THE FUTURE”. The title also reflects the desire to create a program on prevention of HPV-induced neoplasia that looks forward to the future as well as to the present.
Here you will be joined by colleagues who share your commitment to rid our planet of these diseases. Together we can combine our knowledge and voice our collective desire to eliminate cervical cancer and other HPV-related diseases -, not only in high resource countries, but also in the many areas of the world where resources for this task are currently very limited. We are sure that you will return from EUROGIN 2011 energized, and informed on the most up-to date prevention, diagnosis and treatment strategies to further your professional goals.
The conference will be held in the Lisboa Congress Center under the expert leadership of Dr. Joseph Monsonego. The historic capital of Lisbon is the westernmost city in continental Europe, situated on the Tagua Estuary on the Atlantic coast. From here it is easy to explore nearby beaches, countryside, mountains, and areas of historical interest, including the towns of Oeiras, Sintra, Cascais, Estoril, Batalha, Alcobaça and Evora.
We are looking forward to seeing you in Lisbon and sharing in what we are sure will be a most rewarding experience at EUROGIN 2011.
J Thomas Cox (USA), University of California Santa Barbara)
Jack Cuzick (UK), Queen Mary University of London
Carlos De Oliveira (Portugal), University of Coimbra and Federation of the Portuguese Societies of Gynecology and Obstetrics.
Congress Honorary Presidents